Teaching

This role focuses on investigating the molecular basis for synthetic lethality between PRMT inhibition and MYC overexpression or splicing factor mutations in cancer. The position involves conducting research to define the mechanistic effects and therapeutic utility of PRMT inhibitors for specific genetic subsets of cancers. The work aims to identify new therapeutic opportunities for cancer types lacking curative therapies.